D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Visa
V
|
+$319M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$288M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$226M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
Salesforce
CRM
|
+$204M |
Top Sells
| 1 |
PayPal
PYPL
|
+$504M |
| 2 |
Exxon Mobil
XOM
|
+$356M |
| 3 |
Bank of America
BAC
|
+$244M |
| 4 |
Netflix
NFLX
|
+$182M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| 1 | Technology | 19.32% |
| 2 | Financials | 13.76% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
2251
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.29M | ﹤0.01% |
45,656
+7,202
| +19% | +$204K |
|
2252
Centrus Energy
LEU
$4.43B
| $1.29M | ﹤0.01% |
31,493
-19,630
| -38% | -$805K |
|
2253
Cytek Biosciences
CTKB
$504M
| $1.29M | ﹤0.01% |
87,513
-123,289
| -58% | -$1.81M |
|
2254
DocGo
DCGO
$153M
| $1.29M | ﹤0.01% |
129,730
+82,865
| +177% | +$822K |
|
2255
Oscar Health
OSCR
$4.84B
| $1.29M | ﹤0.01% |
+257,949
| New | +$1.29M |
|
2256
Allstate
ALL
$51.9B
| $1.29M | ﹤0.01% |
10,313
+8,713
| +545% | +$1.09M |
|
|
CONN
2257
DELISTED
Conn's Inc.
CONN
| $1.28M | ﹤0.01% |
180,880
-10,617
| -6% | -$75.2K |
|
2258
Prosperity Bancshares
PB
$6.26B
| $1.28M | ﹤0.01% |
+19,196
| New | +$1.28M |
|
|
EMBK
2259
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $1.28M | ﹤0.01% |
172,210
-60,539
| -26% | -$450K |
|
2260
Northfield Bancorp
NFBK
$492M
| $1.28M | ﹤0.01% |
89,272
-38,275
| -30% | -$548K |
|
2261
Samsara
IOT
$22.6B
| $1.28M | ﹤0.01% |
105,747
+70,370
| +199% | +$849K |
|
2262
Puma Biotechnology
PBYI
$234M
| $1.28M | ﹤0.01% |
538,544
-421,528
| -44% | -$999K |
|
2263
OneSpan
OSPN
$596M
| $1.27M | ﹤0.01% |
147,998
+60,559
| +69% | +$521K |
|
2264
Ovid Therapeutics
OVID
$91M
| $1.27M | ﹤0.01% |
691,323
-198,041
| -22% | -$364K |
|
2265
Inspired Entertainment
INSE
$251M
| $1.27M | ﹤0.01% |
143,613
+88,535
| +161% | +$782K |
|
2266
Orthofix Medical
OFIX
$583M
| $1.27M | ﹤0.01% |
66,315
+14,713
| +29% | +$281K |
|
2267
Fidelity National Financial
FNF
$16.3B
| $1.26M | ﹤0.01% |
36,226
-268,951
| -88% | -$9.36M |
|
2268
Photronics
PLAB
$1.35B
| $1.26M | ﹤0.01% |
86,297
+14,489
| +20% | +$212K |
|
2269
Genesco
GCO
$362M
| $1.26M | ﹤0.01% |
32,056
+23,435
| +272% | +$921K |
|
2270
Matrix Service
MTRX
$359M
| $1.26M | ﹤0.01% |
304,271
-4,401
| -1% | -$18.2K |
|
2271
Ezcorp Inc
EZPW
$1.05B
| $1.25M | ﹤0.01% |
162,656
+29,851
| +22% | +$230K |
|
2272
OptimizeRx
OPRX
$322M
| $1.25M | ﹤0.01% |
+84,429
| New | +$1.25M |
|
2273
Gores Guggenheim
PSNY
$2.05B
| $1.25M | ﹤0.01% |
+247,288
| New | +$1.25M |
|
|
HWKZ
2274
DELISTED
Hawks Acquisition Corp
HWKZ
| $1.25M | ﹤0.01% |
127,154
| – | – |
|
|
INBX
2275
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.25M | ﹤0.01% |
69,719
-51,293
| -42% | -$920K |
|